Conclusions: <i>TOPORS</i> activates <i>p53</i>, inhibits <i>PI3K</i>/<i>AKT</i> phosphorylation via SUMOylation, promotes vascular smooth muscle cell (VSMC) apoptosis and inflammation, and exacerbates AD pathogenesis. This evidence concerns the gene TP53 and Alzheimer disease.